Industry Gathers to Tackle Opioid Dependency this May

LONDON, ENGLAND, UNITED KINGDOM, February 1, 2016 /EINPresswire.com/ -- SMi’s 16th annual Pain Therapeutics conference will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research.

Aimed at an audience of senior specialists in neurology, CNS, clinical sciences and pharmacology, Pain Therapeutics 2016 will keep attendees at the forefront of scientific breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery.

Presentations from a selection of leading pharmaceutical companies currently developing novel analgesic treatments including Glenmark, Pfizer, GSK, Grunenthal and Nektar Pharmaceuticals, will provide delegates with an understanding on key topics such as drug development mechanisms, neuropathic pain, severe chronic pain, sodium channels, industry challenges, plus much more! An interactive panel discussion on medical incidents in experimental clinical trials will be just one of the highlights at the conference this spring.

Speaker Line-up Includes:

• Andrea Houghton, Executive Director, MSD (Merck & Co Within The Usa)
• Catherine Stehman-Breen, VP Clinical Sciences, Regeneron Pharmaceuitcals Inc
• Chao Chen, Therapy Area Head, Glaxosmithkline
• Thomas Christoph, Senior Director, Head Of Pain Pharmacology, Grunenthal GmbH
• Richard Butt, Senior Director, Research Project Leader, Clinical Research, Pfizer
• Shaloo Pandhi, Global Program Medical Director, Novartis
• Neelima Khairatkar Joshi, Senior Vice President, Glenmark Pharmaceuticals
• Stephen Doberstein, Senior Vice President & Chief Scientific Officer, Nektar Therapeutics
• Steven Kamerling, Therapeutic Area Head For Pain, Inflammation And Oncology, Zoetis
• Praveen Anand, Professor of Neurology, Imperial College London


For those who are interested in attending, there is currently a £400 early bird saving available online which expires on 29th February. Further information and full speaker line-up is available at www.pain-therapeutics.co.uk

Pain Therapeutics 2016
23 - 24 May 2016
Holiday Inn Kensington Forum, London UK
Sponsored by Centre for Human Drug Research and MD Biosciences

--- end ---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
+442078276000
email us here